Fortis Capital Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-845
Closed -$275K 196
2024
Q1
$275K Buy
+845
New +$207K 0.12% 145
2023
Q1
Sell
-470
Closed -$96.6K 778
2022
Q4
$96.6K Buy
+470
New +$119K 0.06% 223

Other funds holding SWAV

Fortis Capital Advisors's SWAV Position: Q2 2024 in Review

Fortis Capital Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 845 shares — an estimated $275K sold.

Fortis Capital Advisors first reported a position in SWAV in Q4 2022 and held it in 2 quarters. The position peaked at $275K in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Fortis Capital Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Fortis Capital Advisors sold 845 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $275K.
  • Fortis Capital Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
  • Fortis Capital Advisors's Shockwave Medical, Inc. Common Stock position peaked at $275K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Fortis Capital Advisors's 13F filing for Q2 2024, filed 2 Aug 2024.